SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-023035
Filing Date
2023-08-10
Accepted
2023-08-10 16:10:06
Documents
15
Period of Report
2023-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20230809_8k.htm   iXBRL 8-K 25348
2 EXHIBIT 99.1 ex_558146.htm EX-99.1 155282
7 image01.jpg GRAPHIC 9094
  Complete submission text file 0001437749-23-023035.txt   339017

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acrx-20230810.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20230810_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20230810_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20230810_pre.xml EX-101.PRE 11584
9 EXTRACTED XBRL INSTANCE DOCUMENT acrx20230809_8k_htm.xml XML 2572
Mailing Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545
Business Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 231159413
SIC: 2834 Pharmaceutical Preparations